Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: TNS007
MIFTS: 38

Taeniasis

Categories: Infectious diseases
Genes Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Taeniasis

About this section

MalaCards integrated aliases for Taeniasis:

Name: Taeniasis 12 77 15 17
Infection by Taeniarhynchus Saginatus 12
Taenia Saginata Infectious Disease 12
Taenia Saginata Infection 74
Beef Tapeworm Infection 12

Classifications:

MalaCards categories:
Global: Infectious diseases
See all MalaCards categories (disease lists)
ICD10: 34


External Ids:

Disease Ontology 12 DOID:0050596
ICD9CM 36 123.2
SNOMED-CT 69 69163003
ICD10 34 B68 B68.1 B68.9
UMLS 74 C0152073
Sources

Summaries for Taeniasis

About this section
Disease Ontology : 12 A parasitic helminthiasis infectious disease that has material basis in Taenia solium or has material basis in Taenia saginata, which are transmitted by ingestion of undercooked contaminated meat.

MalaCards based summary : Taeniasis, also known as infection by taeniarhynchus saginatus, is related to cysticercosis and echinococcosis. An important gene associated with Taeniasis is MT-CO1 (Mitochondrially Encoded Cytochrome C Oxidase I). The drugs Albendazole and Dexamethasone acetate have been mentioned in the context of this disorder. Affiliated tissues include brain, colon and testes.

Wikipedia : 77 Taeniasis is a parasitic disease due to infection with tapeworms belonging to the genus Taenia. The two... more...

Sources

Related Diseases for Taeniasis

About this section

Diseases related to Taeniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 42)
# Related Disease Score Top Affiliating Genes
1 cysticercosis 33.4 MT-CO1 TACSTD2 TKFC
2 echinococcosis 30.9 IL10 MT-CO1 MT-ND1
3 cystic echinococcosis 30.0 IL10 MT-CO1 MT-ND1
4 parasitic helminthiasis infectious disease 29.8 CTSL IL10 MT-CO1 MT-ND1
5 gnathomiasis 10.2 CTSL MT-CO1
6 coenurosis 10.2 MT-CO1 MT-ND1 TACSTD2
7 ascaris lumbricoides infection 10.2
8 ascaridiasis 10.2
9 deafness, nonsyndromic sensorineural, mitochondrial 10.2 MT-CO1 MT-ND1
10 pediculus humanus capitis infestation 10.2 MT-CO1 MT-CYB
11 amelogenesis imperfecta, type iv 10.1 MT-CO1 MT-CYB
12 myasthenic syndrome, congenital, 10 10.1 MT-CO1 MT-CYB
13 fascioliasis 10.1 CTSL IL10
14 ancylostomiasis 10.1
15 epilepsy 10.1
16 ankylostomiasis 10.1
17 leber optic atrophy 10.0 MT-CO1 MT-CYB MT-ND1
18 sparganosis 10.0 CTSL MT-CO1 MT-CYB
19 intermediate uveitis 10.0 IL10 TGFBR3
20 kearns-sayre syndrome 10.0 MT-CO1 MT-CYB MT-ND1
21 mitochondrial encephalomyopathy 10.0 MT-CO1 MT-CYB MT-ND1
22 mitochondrial myopathy 10.0 MT-CO1 MT-CYB MT-ND1
23 lactic acidosis 10.0 MT-CO1 MT-CYB MT-ND1
24 leber hereditary optic neuropathy 10.0 MT-CO1 MT-CYB MT-ND1
25 parasitic protozoa infectious disease 10.0 IL10 MT-CO1 MT-CYB
26 lymphoma 9.9
27 salmonellosis 9.9
28 hymenolepiasis 9.9
29 chagas disease 9.9
30 shigellosis 9.9
31 megaloblastic anemia 9.9
32 clonorchiasis 9.9
33 schistosomiasis 9.9
34 cholecystitis 9.9
35 gastritis 9.9
36 granulomatous gastritis 9.9
37 enterobiasis 9.9
38 appendicitis 9.9
39 trichinosis 9.9
40 coccidiosis 9.9 IL10 MT-CYB
41 vogt-koyanagi-harada disease 9.9 IL10 TGFBR3
42 familial colorectal cancer 9.8 MT-CO1 MT-CYB

Graphical network of the top 20 diseases related to Taeniasis:



Diseases related to Taeniasis
Sources

Symptoms & Phenotypes for Taeniasis

About this section
Sources

Drugs & Therapeutics for Taeniasis

About this section

Drugs for Taeniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Albendazole Approved, Vet_approved Phase 3,Phase 2,Not Applicable 54965-21-8 2082
2
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 1177-87-3
3
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 50-02-2 5743
4
Omeprazole Approved, Investigational, Vet_approved Phase 3,Phase 2 73590-58-6 4594
5
Praziquantel Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 3,Not Applicable 55268-74-1 4891
6
tannic acid Approved Phase 3 1401-55-4
7
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
8
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
9 Anti-Infective Agents Phase 3,Phase 2,Phase 1,Not Applicable
10 Antiparasitic Agents Phase 3,Phase 2,Phase 1,Not Applicable
11 Antimitotic Agents Phase 3,Phase 2,Not Applicable
12 Antiprotozoal Agents Phase 3,Phase 2,Not Applicable
13 Anthelmintics Phase 3,Phase 2,Phase 1,Not Applicable
14 glucocorticoids Phase 3,Phase 2,Not Applicable
15 HIV Protease Inhibitors Phase 3,Phase 2
16 Autonomic Agents Phase 3,Phase 2,Not Applicable
17 Hormones Phase 3,Phase 2,Not Applicable
18 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Not Applicable
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Not Applicable
20 Anti-Inflammatory Agents Phase 3,Phase 2,Not Applicable
21 Antiemetics Phase 3,Phase 2,Not Applicable
22 Gastrointestinal Agents Phase 3,Phase 2,Not Applicable
23
protease inhibitors Phase 3,Phase 2
24 Anti-Ulcer Agents Phase 3
25 Antacids Phase 3
26 BB 1101 Phase 3,Phase 2,Not Applicable
27 Hormone Antagonists Phase 3,Phase 2,Not Applicable
28 Peripheral Nervous System Agents Phase 3,Phase 2,Not Applicable
29 Proton Pump Inhibitors Phase 3
30 Anticonvulsants Phase 2, Phase 3,Not Applicable
31 Carbonic Anhydrase Inhibitors Phase 2, Phase 3
32 diuretics Phase 2, Phase 3
33 Natriuretic Agents Phase 2, Phase 3
34
Oxfendazole Investigational, Vet_approved Phase 1 53716-50-0 40854
35 Benzimidazole Experimental, Investigational Phase 1 51-17-2
36
Phenytoin Approved, Vet_approved Not Applicable 57-41-0 1775
37
Niclosamide Approved, Investigational, Vet_approved Not Applicable 50-65-7 4477
38
Iodine Approved, Investigational 7553-56-2 807
39 Sodium Channel Blockers Not Applicable
40 Diuretics, Potassium Sparing Not Applicable
41 cadexomer iodine

Interventional clinical trials:

(show all 27)
# Name Status NCT ID Phase Drugs
1 Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Completed NCT02243644 Phase 3 7 days of albendazole 15 mg/kg/day;28 days of albendazole 15 mg/kg/day
2 A Pilot Study of Neurocysticercosis Treatment Completed NCT00283699 Phase 3 albendazole
3 Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients Completed NCT00290823 Phase 3 Albendazole;Dexamethasone;Omeprazole
4 Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) Completed NCT00441285 Phase 2, Phase 3 Praziquantel;Albendazole;ABZ Placebo;PZQ Placebo
5 Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) Recruiting NCT02947581 Phase 3 Albendazole and praziquantel;Albendazole and praziquantel placebo
6 Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) Terminated NCT02945527 Phase 2, Phase 3 Acetazolamide;Dexamethasone
7 RCT ALB for SA Cysticercosis Withdrawn NCT00133458 Phase 3 Albendazole
8 SANCC: Clinical Trial Early Intervention Not yet recruiting NCT03950037 Phase 2 Albendazole
9 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Completed NCT00527579 Phase 1 [F-18]FBR
10 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Completed NCT00526916 Phase 1 [C-11]PBR28
11 Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole Completed NCT02234570 Phase 1 Oxfendazole
12 Single Ascending Dose Safety Study of Oxfendazole Withdrawn NCT01584362 Phase 1 oxfendazole;placebo;oxfendazole;oxfendazole;oxfendazole;oxfendazole;oxfendazole
13 EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso Completed NCT03095339 Not Applicable
14 Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis Completed NCT00001912
15 Taenia Solium Control Case Study in Zambia Completed NCT01368354 Not Applicable
16 Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis Completed NCT00004403 Not Applicable albendazole;dexamethasone;phenytoin
17 Targeted Screening for Taenia Solium Tapeworms Completed NCT01296958 Not Applicable Niclosamide
18 The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania Recruiting NCT03851419
19 Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Zambia Recruiting NCT03874689
20 Treatment of Patients With Cysticercosis With Praziquantel or Albendazole Recruiting NCT00001205
21 Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa? Recruiting NCT02612896 Not Applicable Mass drug administration, praziquantel 10mg/kg
22 A Study for the Ocular Toxocariasis Patients With the Pulmonary Toxocariasis, and Ocular Toxocariasis Cohort Recruiting NCT03814837
23 Intestinal Parasites in Inhabitants of Kuyavian-Pomeranian Province in Poland Recruiting NCT03490435
24 Treatment of Patients With Active Neurocysticercosis in Eastern Africa Not yet recruiting NCT03834337
25 Digital Health Promotion in Iringa, Tanzania Not yet recruiting NCT03808597 Not Applicable
26 People Presenting With Neurocysticercosis in North America Terminated NCT02233855
27 Mass Treatment T Solium Community Study Terminated NCT00138359 Not Applicable Niclosamide

Search NIH Clinical Center for Taeniasis

Sources

Genetic Tests for Taeniasis

About this section
Sources

Anatomical Context for Taeniasis

About this section

MalaCards organs/tissues related to Taeniasis:

42
Brain, Colon, Testes
Sources

Publications for Taeniasis

About this section

Articles related to Taeniasis:

(show top 50) (show all 246)
# Title Authors Year
1
Biliary Taeniasis with Cholecystitis: An Unusual Case of Taenia solium Infection with a Literature Review. ( 30457101 )
2019
2
Spatiotemporal distribution and economic loss associated with bovine cysticercosis and human taeniasis in Ethiopia. ( 30662963 )
2019
3
How to eliminate taeniasis/cysticercosis: porcine vaccination and human chemotherapy (Part 2). ( 30803437 )
2019
4
Identification of a previously unidentified endemic region for taeniasis in North Sumatra, Indonesia. ( 30321521 )
2019
5
Short communication: Four cases of Taenia saginata taeniasis in urban Venezuelan communities. ( 30873931 )
2019
6
Detection of Taenia saginata infection mimicking Crohn's disease using video capsule endoscopy. ( 29636951 )
2018
7
Notes and recommendations for the establishment of control programs for taeniasis and cysticercosis due to Taenia solium in PeruNotes and recommendations for the establishment of control programs for Taeniasis/cysticercosis in Peru. ( 29924259 )
2018
8
Human taeniasis/cysticercosis: a potentially emerging parasitic disease in Europe. ( 29991885 )
2018
9
Towards a cysticercosis-free tropical resort island: A historical overview of taeniasis/cysticercosis in Bali. ( 30385216 )
2018
10
Evaluating Urban Taeniasis as a Threat to Cysticercosis Elimination in Northern Peru. ( 30457096 )
2018
11
Mapping the residual incidence of taeniasis and cysticercosis in Colombia, 2009-2013, using geographical information systems: Implications for public health and travel medicine. ( 29288739 )
2018
12
HDP2: a ribosomal DNA (NTS-ETS) sequence as a target for species-specific molecular diagnosis of intestinal taeniasis in humans. ( 29486767 )
2018
13
On the Visual Diagnosis of Human Taeniasis by Capsule Endoscopy. ( 29914643 )
2018
14
Survey of Obstetrician-Gynecologists in the United States About Taeniasis and Cysticercosis. ( 28077749 )
2017
15
A systematic review of taeniasis, cysticercosis and trichinellosis in Vietnam. ( 28320455 )
2017
16
Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group. ( 28449318 )
2017
17
Development of a health education intervention strategy using an implementation research method to control taeniasis and cysticercosis in Burkina Faso. ( 28569208 )
2017
18
Target product profiles for the diagnosis of Taenia solium taeniasis, neurocysticercosis and porcine cysticercosis. ( 28892472 )
2017
19
Seroprevalence and risk factors of human cysticercosis and taeniasis prevalence in a highly endemic area of epilepsy in Bangoua, west Cameroon. ( 26747010 )
2017
20
Cysticercosis/taeniasis endemicity in Southeast Asia: Current status and control measures. ( 26802488 )
2017
21
Control of Taenia solium taeniasis/cysticercosis: The best way forward for sub-Saharan Africa? ( 27140860 )
2017
22
Geospatial and age-related patterns of Taenia solium taeniasis in the rural health zone of Kimpese, Democratic Republic of Congo. ( 26996821 )
2017
23
Taeniasis in a Spanish girl. ( 27601094 )
2017
24
Human taeniasis: current insights into prevention and management strategies in endemic countries. ( 28615981 )
2017
25
Taeniasis caused by Taenia saginata in Gianyar town and Taenia solium in Karangasem villages of Bali, Indonesia, 2011-2016: How to detect tapeworm carriers, anamnesis or microscopy? ( 28634145 )
2017
26
Taeniasis: An Unusual Presentation. ( 28764162 )
2017
27
Prevalence of Echinococcus granulosus taeniasis in stray dogs in the region of Constantine (North-East Algeria). ( 28929396 )
2017
28
Taeniasis: A possible cause of ileal bleeding. ( 29291202 )
2017
29
Pathogenesis of Taenia solium taeniasis and cysticercosis. ( 26824681 )
2016
30
Taenia solium Taeniasis and Cysticercosis in Southeast Asia. ( 26834197 )
2016
31
GPS Tracking of Free-Ranging Pigs to Evaluate Ring Strategies for the Control of Cysticercosis/Taeniasis in Peru. ( 27035825 )
2016
32
Taeniasis vs cysticercosis infection routes. ( 27262080 )
2016
33
Endoscopy as a diagnostic and therapeutic alternative technique of taeniasis. ( 26219408 )
2016
34
About human taeniasis and Taenia saginata diagnosis by endoscopy. ( 26984440 )
2016
35
Behavioral and hormonal changes associated with the infective dose in experimental taeniasis in golden hamsters (Mesocricetus auratus). ( 27109310 )
2016
36
Taeniasis in non-descript dogs in Ngorongoro, Tanzania: Prevalence and predisposing factors. ( 27247069 )
2016
37
Author´s reply: About human taeniasis and Taenia saginata diagnosis by endoscopy. ( 27650793 )
2016
38
A school based cluster randomised health education intervention trial for improving knowledge and attitudes related to Taenia solium cysticercosis and taeniasis in Mbulu district, northern Tanzania. ( 25719902 )
2015
39
On Taeniasis/Cysticercosis Mimicking Lymphoma on PET/CT Imaging. ( 25899585 )
2015
40
Taeniasis among Refugees Living on Thailand-Myanmar Border, 2012. ( 26401787 )
2015
41
Current status of taeniasis and cysticercosis in Vietnam. ( 24850954 )
2014
42
Immunology of Taenia solium taeniasis and human cysticercosis. ( 24962350 )
2014
43
Taenia solium taeniasis and cysticercosis control and elimination through community-based interventions. ( 25544938 )
2014
44
On taeniasis, hydatidosis and 'figatellu'. ( 24813526 )
2014
45
Recent situation of taeniasis in Mongolia (2002-2012). ( 24850968 )
2014
46
Prevalence and risk factors for Taenia solium taeniasis in Kaniyambadi block, Tamil Nadu, South India. ( 25116828 )
2014
47
Current status and perspectives of cysticercosis and taeniasis in Japan. ( 23467264 )
2013
48
Rare case of disseminated cysticercosis and taeniasis in a Japanese traveler after returning from India. ( 23629930 )
2013
49
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011. ( 23922733 )
2013
50
Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. ( 23947762 )
2013
Sources

Variations for Taeniasis

About this section
Sources

Expression for Taeniasis

About this section
Search GEO for disease gene expression data for Taeniasis.
Sources

Pathways for Taeniasis

About this section
Sources

GO Terms for Taeniasis

About this section

Cellular components related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mitochondrial respiratory chain complex III GO:0005750 8.96 MT-CO1 MT-CYB
2 respiratory chain GO:0070469 8.8 MT-CO1 MT-CYB MT-ND1

Biological processes related to Taeniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 animal organ regeneration GO:0031100 9.26 MT-CYB TGFBR3
2 aerobic respiration GO:0009060 9.16 MT-CO1 MT-ND1
3 response to copper ion GO:0046688 8.96 MT-CO1 MT-CYB
4 electron transport coupled proton transport GO:0015990 8.62 MT-CO1 MT-CYB
Sources

Sources for Taeniasis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....